DrugPatentWatch Database Preview

RENOVA Drug Profile

« Back to Dashboard

When do Renova patents expire, and what generic alternatives are available?

Renova is a drug marketed by Valeant Pharms North and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in RENOVA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for RENOVA

US Patents:	1
Applicants:	1
NDAs:	2
Suppliers / Packagers:	2
Bulk Api Vendors:	112
Patent Applications:	8,956
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for RENOVA
Prior Art and Litigation Support	Order Prior Art and Litigation support for RENOVA
DailyMed Link:	RENOVA at DailyMed

Pharmacology for RENOVA

Drug Class

Retinoid

Medical Subject Heading (MeSH) Categories for RENOVA

Antineoplastic Agents

Keratolytic Agents

Synonyms for RENOVA

.beta.-all-trans-Retinoic acid

.beta.-Retinoic acid

(11Z)-retinoic acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aenoic acid

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid

(2E,4E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid

(4E,6E,8E)-9-(2,6,6-Trimethyl-1-cyclohexenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid

(5E)-Retinoic acid

(9Z,13Z)-Retinoic acid

(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate

(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid

[3H]RA

[3H]Retinoic acid

[3H]tretinoin

[3H]Vitamin A acid

[All-E]-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid

02T794

13497-05-7 (hydrochloride salt)

15-Apo-beta-caroten-15-oic acid

187175-63-9

1cbr

1n4h

2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-

2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)--, (all trans)-

2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-

2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-

2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all trans)-

2,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-

2,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-

3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid-, (all trans)-

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid

3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL)

3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid

3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2E,4E,6E,8E-tetraenoic acid

302-79-4

33998-EP2275420A1

33998-EP2295055A2

33998-EP2295416A2

33998-EP2295426A1

33998-EP2295427A1

33998-EP2298748A2

33998-EP2298764A1

33998-EP2298765A1

33998-EP2298768A1

33998-EP2301928A1

33998-EP2305642A2

33998-EP2308833A2

33998-EP2308861A1

33998-EP2311453A1

33998-EP2311808A1

33998-EP2311829A1

33998-EP2311840A1

4759-48-2

56573-65-0

5688UTC01R

5914-EP2275412A1

5914-EP2292576A2

6-s-trans-retinoic acid

7005-78-9

9-cis-RA

9-cis-retinoic acid (9cRA)

97950-17-9

A-Acido (Argentina)

A-Vitaminsyre

A-Vitaminsyre [Denmark]

AB00052318_18

AB00052318_19

AB00052318-15

AB00052318-16

AB00052318-17

AB03039

AB1009361

Aberel

Aberela

Aberela [Norway]

AC-6824

AC1L9GWO

AC1Q1J2J

Acid A Vit (Belgium, Netherlands)

acide retinoique (French)

Acide retinoique (French) (DSL)

Acnavit

Acnavit [Denmark]

ACT00012

AGN 100335

Airol

AJ-61307

AK-73126

Aknefug

Aknoten

AKOS000280845

All Trans Retinoic Acid

all trans-Retinoic acid

all-(E)-Retinoate

all-(E)-Retinoic acid

All-trans Retinoic Acid

All-trans Retinoic Acid (Tretinoin)

all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid

all-trans-b-Retinoic acid

all-trans-beta-Retinoic acid

all-trans-Retinoate

all-trans-Retinoic acid

all-trans-retinoic acid (ATRA)

all-trans-Retinoic acid, 97%

all-trans-Tretinoin

all-trans-Vitamin A acid

all-trans-Vitamin A1 acid

Alltrans-retinoic acid

Altreno (0.05% lotion)

AN-9660

ARONIS25153

AT-RA

ATRA

ATRA; Tretinoin; Vitamin A acid; all-trans-Retinoic acid

Atragen

Atralin

Avita (0.025% gel)

Avita (TN)

Avita Gel

Avitoin

Avitoin [Norway]

b-Retinoic acid

BC202905

BCP01405

BCPP000036

BDBM31883

beta-Ra

beta-Retinoate

beta-Retinoic acid

Betarretin

BIDD:GT0483

BIDD:PXR0081

BML2-E05

bmse000562

BP-20401

BPBio1_000082

BR-73126

BRD-K06926592-001-01-7

BRD-K71879491-001-15-0

BRD-K71879491-001-22-6

BRN 2057223

BSPBio_000074

BSPBio_001500

C00777

CAS-302-79-4

CCG-39912

CCRIS 3294

CHEBI:15367

CHEMBL38

cid_444795

cis-Retinoic acid

Cordes vas

Cordes VAS [Germany]

CPD000058245

CS-1269

D00094

Dermairol

DSSTox_CID_1239

DSSTox_GSID_21239

DSSTox_RID_76031

DTXSID7021239

Effederm

Effederm [France]

EINECS 206-129-0

Epi-aberel

EU-0101061

Eudyna

GS-3578

GTPL2644

HMS1361K22

HMS1568D16

HMS1791K22

HMS1921D14

HMS1989K22

HMS2089D20

HMS2092N11

HMS2095D16

HMS2236N03

HMS3259E11

HMS3263E04

HMS3402K22

HMS3712D16

HMS502N05

HSDB 2169

HY-14649

I04-0008

I14-2351

IDI1_000903

IDI1_033970

ISORETINOIN

Isotretinoin;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid

J10054

KB-66303

L000833

LMPR01090019

Lopac0_001061

LP01061

LS-1154

MFCD00001551

MLS000028588

MLS001076515

MLS002207234

MLS002222211

MLS002548861

MLS006010222

MolPort-000-883-857

NC00481

NCGC00017280-05

NCGC00017280-06

NCGC00017280-07

NCGC00017280-08

NCGC00017280-09

NCGC00017280-10

NCGC00017280-12

NCGC00017280-15

NCGC00017280-16

NCGC00017280-17

NCGC00017280-18

NCGC00017280-19

NCGC00017280-20

NCGC00017280-23

NCGC00021808-04

NCGC00021808-05

NCGC00021808-06

NCGC00021808-07

NCGC00021808-09

NCGC00021808-11

NCGC00021808-14

NCGC00021808-15

NCGC00254179-01

NCGC00259879-01

NCGC00261746-01

Nexret

NSC 122758

NSC-122758

NSC-759631

NSC122758

NSC759631

Opera_ID_1055

PDT-002-002

Pharmakon1600-01502016

Prestwick_424

Prestwick2_000257

Prestwick3_000257

PubChem16466

Q-200610

QCR-120

R 2625

R0064

REA

Refissa

Renova (0.02% cream)

Renova (TN)

Retacnyl

Retin A

Retin A (TN)

Retin-A

Retin-A Micro

Retinoate

Retinoic acid

Retinoic acid all trans

Retinoic acid, >=98% (HPLC), powder

RETINOIC ACID, ALL TRANS

Retinoic acid, all-trans-

Retinoic acid, all-trans- (8CI)

Retinoic acid, cis-

Retinova

Retionic acid

Retisol-A

Ro 1-5488

RP17637

S-1635

s1653

SAM002264647

SBB065722

SBI-0051031.P003

SC-16932

SCHEMBL19091395

SCHEMBL3145

SHGAZHPCJJPHSC-YCNIQYBTSA-N

SMR000058245

SPECTRUM1502016

Spectrum5_001746

Spectrum5_001933

SR-01000000239

SR-01000000239-12

SR-01000000239-13

SR-01000000239-14

SR-01000000239-15

SR-01000000239-3

SR-01000000239-4

SR-01000000239-6

SR-01000000239-7

ST057075

ST2407905

Stieva-A

SW203749-4

TNP00194

Tox21_110812

Tox21_110812_1

Tox21_202330

Tox21_300305

Tox21_501061

trans-Retinoate

trans-Retinoic acid

trans-Retinoic acid|||Retinoid analogues

Tretin M

tretinoin

Tretinoin - Retinoic Acid

Tretinoin (JAN/USP/INN)

Tretinoin (Retinoic acid)

Tretinoin (TN)

Tretinoin [USAN:INN:BAN]

Tretinoin [USAN:USP:INN:BAN]

Tretinoin 0.1% cream or placebo

tretinoin liposome

Tretinoin, all-trans-

Tretinoin, European Pharmacopoeia (EP) Reference Standard

Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material

Tretinoin, United States Pharmacopeia (USP) Reference Standard

Tretinoin/All-Trans Retinoic Acid

Tretinoina

Tretinoina [INN-Spanish]

Tretinoine

Tretinoine (French)

tretinoine (French) (EINECS)

Tretinoine [INN-French]

Tretinoino

Tretinoino [INN-Spanish]

Tretinoinum

Tretinoinum [INN-Latin]

TRETINON

UNII-5688UTC01R

UPCMLD-DP097

Vesanoid

Vesanoid (TN) (Roche)

Vesnaroid

Vitamin A acid

Vitamin A acid, all-trans-

Vitamin a acid, trans-

Vitamin A1 acid, all-trans-

WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1

WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1

ZINC12358651

US Patents and Regulatory Information for RENOVA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	021108-001	Aug 31, 2000		RX	Yes	Yes
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995	AB2	RX	Yes	Yes

Expired US Patents for RENOVA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	021108-001	Aug 31, 2000
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995